MPM Asset Management LLC
- SEC CIK
- 0001263048
- Latest filing
- Nov 14, 2025
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 6
- 0 vs. Q3 2024
- Portfolio value
- $124.4M
- −$20.9M (−14.4%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | COM | 4,381,062 | $75.7M | 60.9% | −44,722−1.0% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,738,785 | $21.0M | 16.9% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 682,376 | $16.1M | 12.9% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 4,284,172 | $6.34M | 5.1% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 5,555,461 | $2.99M | 2.4% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 1,683,707 | $2.21M | 1.8% | −558,929−24.9% | Reduced | History |